Table of Contents
Table 5-78: Switzerland
Table 5-80: Tipton
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2004 | 2000 - 2004 | 2004 | 2000 - 2004 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 282 | 542.3 | 1,416 | 568.9 | 113 | 227.9 | 615 | 259.2 |
| Esophagus | 7 | 12.4** | 19 | 7.6** | * | # | 23 | 9.0 |
| Stomach | 6 | 11.3** | 23 | 9.0 | * | # | 10 | 3.9** |
| Colon excluding Rectum | 21 | 43.6 | 104 | 42.6 | 7 | 16.6** | 44 | 18.7 |
| Rectum and Rectosigmoid Junction | 6 | 11.7** | 49 | 19.8 | * | # | 13 | 5.5** |
| Liver | 6 | 11.0** | 11 | 4.2** | * | # | 6 | 2.1** |
| Pancreas | * | # | 21 | 8.6 | * | # | 24 | 10.0 |
| Lung and Bronchus | 55 | 109.1 | 267 | 110.4 | 43 | 89.1 | 214 | 88.7 |
| Melanoma of the Skin | 8 | 17.3** | 47 | 17.6 | * | # | 10 | 4.1** |
| Prostate | 71 | 138.5 | 366 | 151.0 | 10 | 22.8** | 59 | 29.3 |
| Urinary Bladder | 22 | 42.7 | 88 | 36.3 | 6 | 11.5** | 17 | 7.4** |
| Kidney and Renal Pelvis | 14 | 26.5** | 60 | 23.5 | 8 | 14.6** | 25 | 10.4 |
| Brain and Other Nervous System | 6 | 11.3** | 24 | 8.6 | * | # | 18 | 6.8** |
| Non-Hodgkin Lymphoma | 16 | 32.9** | 75 | 29.6 | * | # | 23 | 9.8 |
| Myeloma | * | # | 18 | 7.7** | * | # | 13 | 5.9** |
| Leukemia | * | # | 47 | 19.3 | * | # | 32 | 13.5 |
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2004 | 2000 - 2004 | 2004 | 2000 - 2004 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 238 | 363.2 | 1,356 | 424.7 | 99 | 149.3 | 552 | 170.3 |
| Colon excluding Rectum | 19 | 28.5** | 117 | 35.7 | 10 | 15.2** | 48 | 14.1 |
| Rectum and Rectosigmoid Junction | * | # | 33 | 10.3 | * | # | 11 | 3.5** |
| Liver | * | # | 1 | # | * | # | 2 | # |
| Pancreas | * | # | 40 | 12.4 | 8 | 12.6** | 47 | 14.5 |
| Lung and Bronchus | 33 | 53.4 | 166 | 53.0 | 29 | 45.1 | 130 | 41.0 |
| Melanoma of the Skin | 6 | 7.7** | 46 | 14.2 | * | # | 6 | 1.9** |
| Breast | 70 | 107.5 | 411 | 131.5 | 12 | 17.0** | 71 | 22.0 |
| Cervix Uteri | * | # | 20 | 6.2 | * | # | 4 | # |
| Corpus Uteri | 12 | 18.0** | 83 | 26.4 | * | # | 7 | 2.2** |
| Ovary | 10 | 14.9** | 43 | 12.9 | 6 | 7.9** | 35 | 10.9 |
| Urinary Bladder | * | # | 34 | 10.2 | * | # | 5 | 1.6** |
| Kidney and Renal Pelvis | 10 | 16.0** | 39 | 12.2 | * | # | 18 | 5.5** |
| Brain and Other Nervous System | * | # | 15 | 4.7** | * | # | 17 | 5.6** |
| Non-Hodgkin Lymphoma | 12 | 19.3** | 62 | 20.1 | * | # | 17 | 5.1** |
| Myeloma | * | # | 23 | 6.8 | * | # | 11 | 3.1** |
| Leukemia | * | # | 30 | 9.3 | * | # | 20 | 6.4 |
Rates are per 100,000; Age-adjusted, 2000 US Std Population (Census P25-1130).
* Fewer than 5 cases, number suppressed to protect confidentiality.
** Rates based on fewer than 20 cases are unstable.
# Rate cannot be calculated.
Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, June 2007
Table of Contents
Table 5-78: Switzerland
Table 5-80: Tipton
